Swiss pharma and cannabis distributor Astrasana has become the exclusive distributor for Canadian producer Green Karat on the Swiss market. This brings genetics already well-known in European medical markets into closer reach of pharmacies, clinics, and the patients they serve.
📑 Inhaltsverzeichnis
Astrasana has signed an exclusive distribution agreement with Green Karat for the Swiss market. The Canadian company ranks among producers specializing in cannabis genetics and is part of the international medical cannabis market; in Switzerland, the product range will now be offered exclusively through Astrasana. For the market, this is primarily a matter of availability and supply security: an established name is being channeled through a specialized distributor.
Who is Green Karat?
Green Karat is a family-run, licensed cannabis producer from the Canadian province of Québec, north of Montreal. The company has held a license from Health Canada since 2020 and produces in a GMP-certified facility for the international medical market. Its focus is explicitly on genetics and strain development: Green Karat works with renowned breeders and cultivates strains with distinctive terpene profiles. The product range includes strains such as Modified Gas, Runtz OG, and Pavé. These genetics are already established in several European medical markets, which is why many patients are familiar with the name.
What Astrasana Brings to the Table
Astrasana, based in Switzerland, is a vertically integrated pharma and cannabis company that imports medical cannabis, cultivates it domestically in Switzerland, and supplies pharmacies and clinics. The company maintains a growing European distribution network with partners in Switzerland, the Czech Republic, and Germany, and is active in more than 18 countries according to its own information. The exclusive distribution agreement for Green Karat applies solely to the Swiss market; the remainder of the distribution network is unaffected. In Switzerland, the medical cannabis market now serves several thousand patients, whose supply runs through specialized distributors such as Astrasana.
What the Cooperation Means
With exclusivity for Switzerland, Astrasana consolidates Green Karat products for the Swiss market within its portfolio. For prescribing physicians and pharmacies in Switzerland, this creates a clearly defined supply channel for genetics that previously had varying availability depending on the market. Such distribution agreements are a typical building block in the medical cannabis market, where origin, consistency, and regulated supply chains play an increasingly important role. Further details about the product range can be found on the companies‘ websites: Green Karat and Astrasana.
Note: Medical cannabis is available by prescription only. This article provides information about a business distribution cooperation and does not constitute an invitation to use cannabis, a health claim, an efficacy claim, or a product recommendation. Questions regarding medical therapy should be directed to qualified healthcare professionals.
Sponsored content. This article was created in paid cooperation with Astrasana.
Achtest du auf die Herkunft deines medizinischen Cannabis?
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
